Effective response to upadacitinib in patients affected by prurigo nodularis and by atopic dermatitis with a predominant prurigo nodularis pattern: A multicenter case series study

J Am Acad Dermatol. 2024 Nov;91(5):e147-e150. doi: 10.1016/j.jaad.2024.06.094. Epub 2024 Jul 23.
No abstract available

Keywords: JAK inhibitors; atopic dermatitis; itch; prurigo; prurigo nodularis; upadacitinib.

Publication types

  • Letter